BioSig Technologies 2024 Annual Meeting Proxy Statement Filed

TL;DR

BioSig proxy statement out for 2024 annual meeting. Vote your shares!

AI Summary

BioSig Technologies, Inc. is holding its 2024 Annual Meeting of Stockholders on November 18, 2024. The company is filing its Definitive Proxy Statement (DEF 14A) to provide shareholders with information regarding the meeting, including matters to be voted upon, director nominations, and executive compensation. The filing fee for this statement was not required.

Why It Matters

This filing provides shareholders with crucial information to make informed voting decisions on company matters, including the election of directors and executive compensation, directly impacting corporate governance.

Risk Assessment

Risk Level: low — This is a routine proxy filing for an annual shareholder meeting and does not contain new financial or operational disclosures that would inherently increase risk.

Key Players & Entities

• BioSig Technologies, Inc. (company) — Registrant
• November 18, 2024 (date) — Annual Meeting Date
• 2024 (date) — Annual Meeting Year

FAQ

Key Financial Figures

• $0.001 — g shares of our common stock, par value $0.001 per share (“Common Stock”),

Filing Documents

• formdef14a.htm (DEF 14A) — 895KB
• formpre14a_001.jpg (GRAPHIC) — 7KB
• proxy_001.jpg (GRAPHIC) — 71KB
• proxy_002.jpg (GRAPHIC) — 50KB
• 0001493152-24-046504.txt ( ) — 1072KB

EXECUTIVE COMPENSATION

EXECUTIVE COMPENSATION 16 PAY VERSUS PERFORMANCE 25 AUDIT COMMITTEE MATTERS 27 PROPOSAL 2: APPROVAL OF A REVERSE STOCK SPLIT 29 PROPOSAL 3: APPROVAL OF THE SECOND AMENDMENT TO THE BIOSIG TECHNOLOGIES, INC. 2023 LONG-TERM INCENTIVE PLAN 36 PROPOSAL 4: RATIFICATION OF THE APPOINTMENT OF MARCUM LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2023 43 OTHER BUSINESS 44 SUBMISSION OF FUTURE STOCKHOLDER PROPOSALS 44 Annex A – Form of Certificate of Amendment of Amended and Restated Certificate of Incorporation of BioSig Technologies, Inc. A-1 Annex B – Second Amendment to the BioSig Technologies, Inc. 2023 Long-Term Incentive Plan B-1 Annex C – BioSig Technologies, Inc. 2023 Long-Term Incentive Plan C-1 Form of Proxy Card BIOSIG TECHNOLOGIES, INC. 12424 Wilshire Blvd., Suite 745 Los Angeles, CA 90025 (203) 409-5444 PROXY FOR ANNUAL MEETING OF STOCKHOLDERS To Be Held December 31, 2024 Unless the context otherwise requires, references in this proxy statement (the “Proxy Statement”) to “we,” “us,” “our,” “the Company,” or “BioSig” refer to BioSig Technologies, Inc., a Delaware corporation, and its consolidated subsidiaries as a whole. In addition, unless the context otherwise requires, references to “stockholders” are to the holders of our voting securities, which consist of our common stock, par value $0.001 per share (the “Common Stock”), and our Series C Convertible Preferred Stock (the “Series C Preferred Stock”) entitled to vote at the 2024 annual meeting of stockholders of the Company (the “Annual Meeting”). The accompanying proxy is solicited by the Board of Directors (the “Board”) on behalf of BioSig to be voted at the Annual Meeting to be held on December 31, 2023, at the time and place and for the

View Full Filing

View this DEF 14A filing on SEC EDGAR